Erdafitinib Update – Metastatic Urothelial Cancer
Arlene O. Siefker-Radtke, MD, explores the evolving role of erdafitinib in treating FGFR3-altered urothelial carcinoma.
Read More
International Bladder Cancer Update
Implications of EV 302 How do We Sequence Treatment in the Future
Shilpa Gupta, MD, explores the evolving treatment paradigm in metastatic urothelial carcinoma following the EV-302 trial.
Read More
UTUC Staging, Diagnosis, Intraureteralpelvis Therapy, Endoscopic Management
Jennifer A. Linehan, MD, examines strategies for managing upper tract UTUC, highlighting diagnosis, staging, and treatment selection.
Read More
BCG Unresponsive Intravesical Therapy
Piyush K. Agarwal, MD, explores the evolving landscape of treatments for BCG-unresponsive bladder cancer.
Read More
Perioperative Chemotherapy for Upper Tract Urothelial Cancer
Robert Dreicer, MD, MS, MACP, FASCO, highlights the complexities of managing high-grade urothelial carcinoma of the upper tract.
Read More